Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $41.7M | $37.3M | $34.1M | $28.7M | $24.1M | $18.8M |
| Research & development | $3.7M | $2.1M | $77,000 | $0 | — | — |
| Operating expenses | $53.1M | $54.5M | $56.7M | $47.3M | $49.3M | $28.5M |
| Operating income | −$11.3M | −$17.2M | −$22.7M | −$18.6M | −$25.2M | −$9.6M |
| Operating margin | −27.21% | −46.11% | −66.56% | −64.80% | −104.57% | −50.96% |
| EBITDA | −$11.2M | −$16.8M | −$22.1M | −$18.1M | −$24.7M | −$9.0M |
| EBITDA margin | −26.88% | −44.99% | −64.80% | −62.99% | −102.33% | −47.98% |
| Net income | −$10.5M | −$17.8M | −$20.1M | −$640,000 | −$37.7M | −$11.0M |
| Net profit margin | −25.26% | −47.58% | −59.09% | −2.23% | −156.49% | −58.29% |
| Basic EPSper basic share | -$1.04 | -$3.22 | -$13.02 | -$0.61 | -$4.28 | -$0.48 |
| Diluted EPSper diluted share | -$1.04 | -$3.22 | -$13.02 | -$0.61 | -$4.28 | -$0.48 |
Reported shareholders
| Holder | % owned |
|---|---|
Rosalind Advisors, Inc. | 8.98%1.28M shares |
AIGH Capital Management LLC | 5.21%739.91K shares |
Zours Wilhelm Konrad Thomas | ≈3.23%458.88K shares |
VV Beteiligungen Aktiengesellschaft | ≈3.23%458.88K shares |
DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFT | ≈3.23%458.88K shares |
DEUTSCHE BALATON AKTIENGESELLSCHAFT | ≈3.23%458.88K shares |
Biofrontera AG | ≈2.82%400K shares |
de la Huerta Martinez Maria del Pilar | ≈2.82%400K shares |
Luebbert Hermann | ≈2.04%290.21K shares |
Leffler Eugene Frederick | ≈1.23%175K shares |
RENAISSANCE TECHNOLOGIES LLC | 1.11%157.51K shares |
CITADEL ADVISORS LLC | 0.74%104.94K shares |
JANE STREET GROUP, LLC | 0.65%93K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.54%76.69K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.50%71.38K shares |
VANGUARD FIDUCIARY TRUST CO | 0.43%61.7K shares |
XTX Topco Ltd | 0.37%51.89K shares |
HRT FINANCIAL LP | 0.31%43.35K shares |
NORTHERN TRUST CORP | 0.22%31.54K shares |
UBS Group AG | 0.13%18.52K shares |
Percentages use 14.21M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Sep 16, 2025Form 4 | Biofrontera AGDirector,TenPercentOwner | BuySeries D Convertible Preferred Stock · derivative | 3.0K | — | — | 3.0K |